186 related articles for article (PubMed ID: 12444908)
1. Substrate utilization in non-obese Type II diabetic patients at rest and during exercise.
Borghouts LB; Wagenmakers AJ; Goyens PL; Keizer HA
Clin Sci (Lond); 2002 Dec; 103(6):559-66. PubMed ID: 12444908
[TBL] [Abstract][Full Text] [Related]
2. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise.
Blaak EE; van Aggel-Leijssen DP; Wagenmakers AJ; Saris WH; van Baak MA
Diabetes; 2000 Dec; 49(12):2102-7. PubMed ID: 11118013
[TBL] [Abstract][Full Text] [Related]
3. Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes.
Mensink M; Blaak EE; van Baak MA; Wagenmakers AJ; Saris WH
Diabetes; 2001 Nov; 50(11):2548-54. PubMed ID: 11679433
[TBL] [Abstract][Full Text] [Related]
4. Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects.
Blaak EE; Wolffenbuttel BH; Saris WH; Pelsers MM; Wagenmakers AJ
J Clin Endocrinol Metab; 2001 Apr; 86(4):1638-44. PubMed ID: 11297597
[TBL] [Abstract][Full Text] [Related]
5. Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery.
Boon H; Blaak EE; Saris WH; Keizer HA; Wagenmakers AJ; van Loon LJ
Diabetologia; 2007 Jan; 50(1):103-12. PubMed ID: 17131144
[TBL] [Abstract][Full Text] [Related]
6. Effects of obesity on substrate utilization during exercise.
Goodpaster BH; Wolfe RR; Kelley DE
Obes Res; 2002 Jul; 10(7):575-84. PubMed ID: 12105277
[TBL] [Abstract][Full Text] [Related]
7. Utilization of glycogen but not plasma glucose is reduced in individuals with NIDDM during mild-intensity exercise.
Colberg SR; Hagberg JM; McCole SD; Zmuda JM; Thompson PD; Kelley DE
J Appl Physiol (1985); 1996 Nov; 81(5):2027-33. PubMed ID: 8941525
[TBL] [Abstract][Full Text] [Related]
8. Substrate source utilization during moderate intensity exercise with glucose ingestion in Type 1 diabetic patients.
Robitaille M; Dubé MC; Weisnagel SJ; Prud'homme D; Massicotte D; Péronnet F; Lavoie C
J Appl Physiol (1985); 2007 Jul; 103(1):119-24. PubMed ID: 17431081
[TBL] [Abstract][Full Text] [Related]
9. Intramyocellular lipids form an important substrate source during moderate intensity exercise in endurance-trained males in a fasted state.
van Loon LJ; Koopman R; Stegen JH; Wagenmakers AJ; Keizer HA; Saris WH
J Physiol; 2003 Dec; 553(Pt 2):611-25. PubMed ID: 14514877
[TBL] [Abstract][Full Text] [Related]
10. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle.
Blaak EE; Wagenmakers AJ; Glatz JF; Wolffenbuttel BH; Kemerink GJ; Langenberg CJ; Heidendal GA; Saris WH
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E146-54. PubMed ID: 10893334
[TBL] [Abstract][Full Text] [Related]
11. Effects of beta-adrenergic receptor stimulation and blockade on substrate metabolism during submaximal exercise.
Mora-Rodriguez R; Hodgkinson BJ; Byerley LO; Coyle EF
Am J Physiol Endocrinol Metab; 2001 May; 280(5):E752-60. PubMed ID: 11287358
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid kinetics and carbohydrate metabolism during electrical exercise in spinal cord-injured humans.
Kjaer M; Dela F; Sørensen FB; Secher NH; Bangsbo J; Mohr T; Galbo H
Am J Physiol Regul Integr Comp Physiol; 2001 Nov; 281(5):R1492-8. PubMed ID: 11641120
[TBL] [Abstract][Full Text] [Related]
13. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
[TBL] [Abstract][Full Text] [Related]
14. Fuel substrate kinetics of carbohydrate loading differs from that of carbohydrate ingestion during prolonged exercise.
Bosch AN; Weltan SM; Dennis SC; Noakes TD
Metabolism; 1996 Apr; 45(4):415-23. PubMed ID: 8609825
[TBL] [Abstract][Full Text] [Related]
15. Preexercise medium-chain triglyceride ingestion does not alter muscle glycogen use during exercise.
Horowitz JF; Mora-Rodriguez R; Byerley LO; Coyle EF
J Appl Physiol (1985); 2000 Jan; 88(1):219-25. PubMed ID: 10642384
[TBL] [Abstract][Full Text] [Related]
16. Exogenous insulin replacement in type 2 diabetes reverses excessive hepatic glucose release, but not excessive renal glucose release and impaired free fatty acid clearance.
Woerle HJ; Popa E; Dostou J; Welle S; Gerich J; Meyer C
Metabolism; 2002 Nov; 51(11):1494-500. PubMed ID: 12404204
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise intensity and training on lipid metabolism in young women.
Friedlander AL; Casazza GA; Horning MA; Buddinger TF; Brooks GA
Am J Physiol; 1998 Nov; 275(5):E853-63. PubMed ID: 9815006
[TBL] [Abstract][Full Text] [Related]
18. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes.
Boden G; Chen X; Capulong E; Mozzoli M
Diabetes; 2001 Apr; 50(4):810-6. PubMed ID: 11289046
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of adipose tissue lipolysis increases intramuscular lipid use in type 2 diabetic patients.
van Loon LJ; Manders RJ; Koopman R; Kaastra B; Stegen JH; Gijsen AP; Saris WH; Keizer HA
Diabetologia; 2005 Oct; 48(10):2097-107. PubMed ID: 16096823
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate supplementation during prolonged cycling exercise spares muscle glycogen but does not affect intramyocellular lipid use.
Stellingwerff T; Boon H; Gijsen AP; Stegen JH; Kuipers H; van Loon LJ
Pflugers Arch; 2007 Jul; 454(4):635-47. PubMed ID: 17333244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
